Example of Prenatal Diagnosis format
Recent searches

Example of Prenatal Diagnosis format Example of Prenatal Diagnosis format Example of Prenatal Diagnosis format Example of Prenatal Diagnosis format Example of Prenatal Diagnosis format Example of Prenatal Diagnosis format Example of Prenatal Diagnosis format
Sample paper formatted on SciSpace - SciSpace
This content is only for preview purposes. The original open access content can be found here.
Look Inside
Example of Prenatal Diagnosis format Example of Prenatal Diagnosis format Example of Prenatal Diagnosis format Example of Prenatal Diagnosis format Example of Prenatal Diagnosis format Example of Prenatal Diagnosis format Example of Prenatal Diagnosis format
Sample paper formatted on SciSpace - SciSpace
This content is only for preview purposes. The original open access content can be found here.
open access Open Access

Prenatal Diagnosis — Template for authors

Publisher: Wiley
Categories Rank Trend in last 3 yrs
Obstetrics and Gynecology #33 of 176 up up by 6 ranks
Genetics (clinical) #45 of 87 down down by 1 rank
journal-quality-icon Journal quality:
High
calendar-icon Last 4 years overview: 653 Published Papers | 2794 Citations
indexed-in-icon Indexed in: Scopus
last-updated-icon Last updated: 04/07/2020
Related journals
Insights
General info
Top papers
Popular templates
Get started guide
Why choose from SciSpace
FAQ

Related Journals

open access Open Access

Springer

Quality:  
High
CiteRatio: 4.2
SJR: 0.966
SNIP: 1.086
open access Open Access

Taylor and Francis

Quality:  
High
CiteRatio: 4.2
SJR: 0.747
SNIP: 1.109
open access Open Access

SAGE

Quality:  
High
CiteRatio: 4.5
SJR: 0.927
SNIP: 0.926
open access Open Access

Hindawi

Quality:  
High
CiteRatio: 4.1
SJR: 1.18
SNIP: 1.896

Journal Performance & Insights

Impact Factor

CiteRatio

Determines the importance of a journal by taking a measure of frequency with which the average article in a journal has been cited in a particular year.

A measure of average citations received per peer-reviewed paper published in the journal.

2.425

0% from 2018

Impact factor for Prenatal Diagnosis from 2016 - 2019
Year Value
2019 2.425
2018 2.434
2017 2.779
2016 2.523
graph view Graph view
table view Table view

4.3

2% from 2019

CiteRatio for Prenatal Diagnosis from 2016 - 2020
Year Value
2020 4.3
2019 4.4
2018 5.1
2017 4.3
2016 5.4
graph view Graph view
table view Table view

insights Insights

  • Impact factor of this journal has decreased by 0% in last year.
  • This journal’s impact factor is in the top 10 percentile category.

insights Insights

  • CiteRatio of this journal has decreased by 2% in last years.
  • This journal’s CiteRatio is in the top 10 percentile category.

SCImago Journal Rank (SJR)

Source Normalized Impact per Paper (SNIP)

Measures weighted citations received by the journal. Citation weighting depends on the categories and prestige of the citing journal.

Measures actual citations received relative to citations expected for the journal's category.

0.956

10% from 2019

SJR for Prenatal Diagnosis from 2016 - 2020
Year Value
2020 0.956
2019 1.067
2018 1.523
2017 1.139
2016 1.329
graph view Graph view
table view Table view

1.214

2% from 2019

SNIP for Prenatal Diagnosis from 2016 - 2020
Year Value
2020 1.214
2019 1.185
2018 1.074
2017 1.018
2016 1.113
graph view Graph view
table view Table view

insights Insights

  • SJR of this journal has decreased by 10% in last years.
  • This journal’s SJR is in the top 10 percentile category.

insights Insights

  • SNIP of this journal has increased by 2% in last years.
  • This journal’s SNIP is in the top 10 percentile category.

Prenatal Diagnosis

Guideline source: View

All company, product and service names used in this website are for identification purposes only. All product names, trademarks and registered trademarks are property of their respective owners.

Use of these names, trademarks and brands does not imply endorsement or affiliation. Disclaimer Notice

Wiley

Prenatal Diagnosis

Prenatal Diagnosis communicates the results of clinical and basic research in prenatal and preimplantation diagnosis in humans, and animal and in vitro models, encompassing all aspects of fetal imaging, prenatal cytogenetics, prenatal screening studies, fetal cells and cell-fr...... Read More

Obstetrics and Gynaecology

Genetics(clinical)

Medicine

i
Last updated on
03 Jul 2020
i
ISSN
0197-3851
i
Impact Factor
High - 1.228
i
Open Access
Yes
i
Sherpa RoMEO Archiving Policy
Yellow faq
i
Plagiarism Check
Available via Turnitin
i
Endnote Style
Download Available
i
Bibliography Name
apa
i
Citation Type
Numbered
[25]
i
Bibliography Example
Yamakage A, Sato M, Yada K, Kashiwaya S, Tanaka Y. Anomalous Josephson current in superconducting topological insulator. Phys Rev B. 2013;87(10):100510.

Top papers written in this journal

Journal Article DOI: 10.1002/PD.2637
Screening for fetal aneuploidies at 11 to 13 weeks
Kypros H. Nicolaides1
01 Jan 2011 - Prenatal Diagnosis

Abstract:

Effective screening for major aneuploidies can be provided in the first trimester of pregnancy. Screening by a combination of fetal nuchal translucency and maternal serum free-β-human chorionic gonadotrophin and pregnancy-associated plasma protein-A can identify about 90% of fetuses with trisomy 21 and other major aneuploidie... Effective screening for major aneuploidies can be provided in the first trimester of pregnancy. Screening by a combination of fetal nuchal translucency and maternal serum free-β-human chorionic gonadotrophin and pregnancy-associated plasma protein-A can identify about 90% of fetuses with trisomy 21 and other major aneuploidies for a false-positive rate of 5%. Improvement in the performance of first-trimester screening can be achieved by firstly, inclusion in the ultrasound examination assessment of the nasal bone and flow in the ductus venosus, hepatic artery and across the tricuspid valve, and secondly, carrying out the biochemical test at 9 to 10 weeks and the ultrasound scan at 12 weeks. read more read less

Topics:

Prenatal diagnosis (57%)57% related to the paper, Ductus venosus (56%)56% related to the paper, Nuchal Translucency Measurement (53%)53% related to the paper, Pregnancy-associated plasma protein A (53%)53% related to the paper
View PDF
551 Citations
Journal Article DOI: 10.1002/PD.1970070904
Abnormal maternal serum chorionic gonadotropin levels in pregnancies with fetal chromosome abnormalities
Mark H. Bogart1, M. R. Pandian, Oliver W. Jones1
01 Nov 1987 - Prenatal Diagnosis

Abstract:

The alpha subunit of human chorionic gonadotropin (alpha-hCG), human chorionic gonadotropin (hCG) and alpha fetoprotein (AFP) were measured in the serum of 25 women with chromosomally abnormal fetuses between 18 and 25 weeks of gestation and in 74 normal pregnancies. AFP levels less than 0.5 multiples of the median (MoM) or g... The alpha subunit of human chorionic gonadotropin (alpha-hCG), human chorionic gonadotropin (hCG) and alpha fetoprotein (AFP) were measured in the serum of 25 women with chromosomally abnormal fetuses between 18 and 25 weeks of gestation and in 74 normal pregnancies. AFP levels less than 0.5 multiples of the median (MoM) or greater than 2.5 MoM were observed in 24 per cent of the abnormal pregnancies and in 6.76 per cent of the normal pregnancies. A low concentration of hCG ( 2.5 MoM) was observed in 56 per cent of abnormals and in 1.35 per cent of normals. Elevated hCG-alpha (>2.5 MoM) was observed in 28 per cent of abnormals and in none of the normals. Determination of elevated levels of hCG-alpha or hCG resulted in detection of 68 per cent of pregnancies with chromosomally abnormal fetuses with a false positive rate of 1.35 per cent. Determination of both elevated and depressed gonadotropin levels resulted in detection of 76 per cent of abnormal pregnancies with a false positive rate of 4.05 per cent. Measurement of hCG and hCG-alpha in maternal serum samples can be used as a screening procedure for detecting pregnancies at risk for fetal chromosome abnormalities. read more read less

Topics:

Gonadotropin (51%)51% related to the paper, Human chorionic gonadotropin (50%)50% related to the paper
478 Citations
Journal Article DOI: 10.1002/PD.2660
Prediction of early, intermediate and late pre-eclampsia from maternal factors, biophysical and biochemical markers at 11-13 weeks.
01 Jan 2011 - Prenatal Diagnosis

Abstract:

Objective To develop models for prediction of pre-eclampsia (PE) based on maternal factors and biophysical and biochemical markers at 11–13 weeks' gestation. Methods Screening study of singleton pregnancies at 11–13 weeks including 752 (2.2%) that subsequently developed PE and 32 850 that were unaffected by PE. Models we... Objective To develop models for prediction of pre-eclampsia (PE) based on maternal factors and biophysical and biochemical markers at 11–13 weeks' gestation. Methods Screening study of singleton pregnancies at 11–13 weeks including 752 (2.2%) that subsequently developed PE and 32 850 that were unaffected by PE. Models were developed for the prediction of early PE, requiring delivery before 34 weeks, intermediate PE with delivery at 34–37 weeks and late PE delivering after 37 weeks. The data used for the models were firstly, maternal characteristics and history, uterine artery pulsatility index, mean arterial pressure and serum pregnancy-associated plasma protein-A obtained from the screening study and secondly, maternal serum or plasma concentration of placental growth factor, placental protein-13, inhibin-A, activin-A, soluble endoglin, pentraxin-3 and P-selectin obtained from case-control studies. Results In screening for PE by maternal factors only at a fixed false positive rate of 5%, the estimated detection rates were 33.0% for early PE, 27.8% for intermediate PE and 24.5% for late PE. The respective detection rates in screening by a combination of maternal factors, biophysical and biochemical markers were 91.0, 79.4 and 60.9%. Conclusions Effective prediction of PE can be achieved at 11–13 weeks' gestation. Copyright © 2011 John Wiley & Sons, Ltd. read more read less
View PDF
432 Citations
Journal Article DOI: 10.1002/PD.2642
Challenges in the diagnosis of fetal non‐chromosomal abnormalities at 11–13 weeks
01 Jan 2011 - Prenatal Diagnosis

Abstract:

Objective To examine the performance of the 11–13 weeks scan in detecting non-chromosomal abnormalities. Methods Prospective first-trimester screening study for aneuploidies, including basic examination of the fetal anatomy, in 45 191 pregnancies. Findings were compared to those at 20–23 weeks and postnatal examination. ... Objective To examine the performance of the 11–13 weeks scan in detecting non-chromosomal abnormalities. Methods Prospective first-trimester screening study for aneuploidies, including basic examination of the fetal anatomy, in 45 191 pregnancies. Findings were compared to those at 20–23 weeks and postnatal examination. Results Aneuploidies (n = 332) were excluded from the analysis. Fetal abnormalities were observed in 488 (1.1%) of the remaining 44 859 cases; 213 (43.6%) of these were detected at 11–13 weeks. The early scan detected all cases of acrania, alobar holoprosencephaly, exomphalos, gastroschisis, megacystis and body stalk anomaly, 77% of absent hand or foot, 50% of diaphragmatic hernia, 50% of lethal skeletal dysplasias, 60% of polydactyly, 34% of major cardiac defects, 5% of facial clefts and 14% of open spina bifida, but none of agenesis of the corpus callosum, cerebellar or vermian hypoplasia, echogenic lung lesions, bowel obstruction, most renal defects or talipes. Nuchal translucency (NT) was above the 95th percentile in 34% of fetuses with major cardiac defects. Conclusion At 11–13 weeks some abnormalities are always detectable, some can never be and others are potentially detectable depending on their association with increased NT, the phenotypic expression of the abnormality with gestation and the objectives set for such a scan. Copyright © 2011 John Wiley & Sons, Ltd. read more read less

Topics:

Prenatal diagnosis (57%)57% related to the paper, Acrania (53%)53% related to the paper, Megacystis (52%)52% related to the paper, Agenesis of the corpus callosum (51%)51% related to the paper
View PDF
397 Citations
Journal Article DOI: 10.1002/PD.1970040704
Maternal age specific rates for chromosome aberrations and factors influencing them: Report of a collaborative european study on 52 965 amniocenteses
Malcolm A. Ferguson-Smith1, J. R. W. Yates1
01 Nov 1984 - Prenatal Diagnosis

Abstract:

Maternal age specific rates for all major chromosome aberrations have been determined in 52 965 pregnancies in mothers 35 years of age and over at the time of amniocentesis. Rates increase exponentially with advancing maternal age for trisomies 21, 18 and 13, and for the XXX and XXY syndromes, but in the autosomal trisomies t... Maternal age specific rates for all major chromosome aberrations have been determined in 52 965 pregnancies in mothers 35 years of age and over at the time of amniocentesis. Rates increase exponentially with advancing maternal age for trisomies 21, 18 and 13, and for the XXX and XXY syndromes, but in the autosomal trisomies this rise appears to be followed by a levelling off at the upper end of the age range. A significant inverse relationship with maternal age is found for 45,X cases. It is postulated that these various patterns are the result of the interaction of three principal factors: a maternal age effect acting particularly on first meiotic nondisjunction: a higher spontaneous abortion rate with advancing maternal age for aneuploid as compared to euploid conceptions; and an increased probability of spontaneous abortion before the time of amniocentesis for conceptions with more extensive chromosome imbalance. A stepwise logistic regression analysis of 13 299 pregnancies in which both parental ages are known shows that the father's age does not influence these maternal age specific rates, with the possible exception of the 47,XXY syndrome. read more read less

Topics:

Paternal age effect (55%)55% related to the paper, Amniocentesis (51%)51% related to the paper
391 Citations
Author Pic

SciSpace is a very innovative solution to the formatting problem and existing providers, such as Mendeley or Word did not really evolve in recent years.

- Andreas Frutiger, Researcher, ETH Zurich, Institute for Biomedical Engineering

Get MS-Word and LaTeX output to any Journal within seconds
1
Choose a template
Select a template from a library of 40,000+ templates
2
Import a MS-Word file or start fresh
It takes only few seconds to import
3
View and edit your final output
SciSpace will automatically format your output to meet journal guidelines
4
Submit directly or Download
Submit to journal directly or Download in PDF, MS Word or LaTeX

(Before submission check for plagiarism via Turnitin)

clock Less than 3 minutes

What to expect from SciSpace?

Speed and accuracy over MS Word

''

With SciSpace, you do not need a word template for Prenatal Diagnosis.

It automatically formats your research paper to Wiley formatting guidelines and citation style.

You can download a submission ready research paper in pdf, LaTeX and docx formats.

Time comparison

Time taken to format a paper and Compliance with guidelines

Plagiarism Reports via Turnitin

SciSpace has partnered with Turnitin, the leading provider of Plagiarism Check software.

Using this service, researchers can compare submissions against more than 170 million scholarly articles, a database of 70+ billion current and archived web pages. How Turnitin Integration works?

Turnitin Stats
Publisher Logos

Freedom from formatting guidelines

One editor, 100K journal formats – world's largest collection of journal templates

With such a huge verified library, what you need is already there.

publisher-logos

Easy support from all your favorite tools

Prenatal Diagnosis format uses apa citation style.

Automatically format and order your citations and bibliography in a click.

SciSpace allows imports from all reference managers like Mendeley, Zotero, Endnote, Google Scholar etc.

Frequently asked questions

1. Can I write Prenatal Diagnosis in LaTeX?

Absolutely not! Our tool has been designed to help you focus on writing. You can write your entire paper as per the Prenatal Diagnosis guidelines and auto format it.

2. Do you follow the Prenatal Diagnosis guidelines?

Yes, the template is compliant with the Prenatal Diagnosis guidelines. Our experts at SciSpace ensure that. If there are any changes to the journal's guidelines, we'll change our algorithm accordingly.

3. Can I cite my article in multiple styles in Prenatal Diagnosis?

Of course! We support all the top citation styles, such as APA style, MLA style, Vancouver style, Harvard style, and Chicago style. For example, when you write your paper and hit autoformat, our system will automatically update your article as per the Prenatal Diagnosis citation style.

4. Can I use the Prenatal Diagnosis templates for free?

Sign up for our free trial, and you'll be able to use all our features for seven days. You'll see how helpful they are and how inexpensive they are compared to other options, Especially for Prenatal Diagnosis.

5. Can I use a manuscript in Prenatal Diagnosis that I have written in MS Word?

Yes. You can choose the right template, copy-paste the contents from the word document, and click on auto-format. Once you're done, you'll have a publish-ready paper Prenatal Diagnosis that you can download at the end.

6. How long does it usually take you to format my papers in Prenatal Diagnosis?

It only takes a matter of seconds to edit your manuscript. Besides that, our intuitive editor saves you from writing and formatting it in Prenatal Diagnosis.

7. Where can I find the template for the Prenatal Diagnosis?

It is possible to find the Word template for any journal on Google. However, why use a template when you can write your entire manuscript on SciSpace , auto format it as per Prenatal Diagnosis's guidelines and download the same in Word, PDF and LaTeX formats? Give us a try!.

8. Can I reformat my paper to fit the Prenatal Diagnosis's guidelines?

Of course! You can do this using our intuitive editor. It's very easy. If you need help, our support team is always ready to assist you.

9. Prenatal Diagnosis an online tool or is there a desktop version?

SciSpace's Prenatal Diagnosis is currently available as an online tool. We're developing a desktop version, too. You can request (or upvote) any features that you think would be helpful for you and other researchers in the "feature request" section of your account once you've signed up with us.

10. I cannot find my template in your gallery. Can you create it for me like Prenatal Diagnosis?

Sure. You can request any template and we'll have it setup within a few days. You can find the request box in Journal Gallery on the right side bar under the heading, "Couldn't find the format you were looking for like Prenatal Diagnosis?”

11. What is the output that I would get after using Prenatal Diagnosis?

After writing your paper autoformatting in Prenatal Diagnosis, you can download it in multiple formats, viz., PDF, Docx, and LaTeX.

12. Is Prenatal Diagnosis's impact factor high enough that I should try publishing my article there?

To be honest, the answer is no. The impact factor is one of the many elements that determine the quality of a journal. Few of these factors include review board, rejection rates, frequency of inclusion in indexes, and Eigenfactor. You need to assess all these factors before you make your final call.

13. What is Sherpa RoMEO Archiving Policy for Prenatal Diagnosis?

SHERPA/RoMEO Database

We extracted this data from Sherpa Romeo to help researchers understand the access level of this journal in accordance with the Sherpa Romeo Archiving Policy for Prenatal Diagnosis. The table below indicates the level of access a journal has as per Sherpa Romeo's archiving policy.

RoMEO Colour Archiving policy
Green Can archive pre-print and post-print or publisher's version/PDF
Blue Can archive post-print (ie final draft post-refereeing) or publisher's version/PDF
Yellow Can archive pre-print (ie pre-refereeing)
White Archiving not formally supported
FYI:
  1. Pre-prints as being the version of the paper before peer review and
  2. Post-prints as being the version of the paper after peer-review, with revisions having been made.

14. What are the most common citation types In Prenatal Diagnosis?

The 5 most common citation types in order of usage for Prenatal Diagnosis are:.

S. No. Citation Style Type
1. Author Year
2. Numbered
3. Numbered (Superscripted)
4. Author Year (Cited Pages)
5. Footnote

15. How do I submit my article to the Prenatal Diagnosis?

It is possible to find the Word template for any journal on Google. However, why use a template when you can write your entire manuscript on SciSpace , auto format it as per Prenatal Diagnosis's guidelines and download the same in Word, PDF and LaTeX formats? Give us a try!.

16. Can I download Prenatal Diagnosis in Endnote format?

Yes, SciSpace provides this functionality. After signing up, you would need to import your existing references from Word or Bib file to SciSpace. Then SciSpace would allow you to download your references in Prenatal Diagnosis Endnote style according to Elsevier guidelines.

Fast and reliable,
built for complaince.

Instant formatting to 100% publisher guidelines on - SciSpace.

Available only on desktops 🖥

No word template required

Typset automatically formats your research paper to Prenatal Diagnosis formatting guidelines and citation style.

Verifed journal formats

One editor, 100K journal formats.
With the largest collection of verified journal formats, what you need is already there.

Trusted by academicians

I spent hours with MS word for reformatting. It was frustrating - plain and simple. With SciSpace, I can draft my manuscripts and once it is finished I can just submit. In case, I have to submit to another journal it is really just a button click instead of an afternoon of reformatting.

Andreas Frutiger
Researcher & Ex MS Word user
Use this template